Copy
View this email in your browser
Philip Morris CEO:
We need to find cigarette alternatives
 
A CNBC interview at Davos yesterday with André Calantzopoulos, CEO of Philip Morris International, reveals that the company that sells Marlboro outside the US believes it “needs to find cigarette alternatives.”
 
In 2003, Philip Morris Companies changed its name to Altria, some say to distance itself from its historical association with tobacco. Five years later, Altria split off Philip Morris International, which handles all Philip Morris production and sales globally but not in the US.
 
Philip Morris International has heavily invested in the development of an e-cigarette device called iQOS, which is used by 4 million people in 30 global markets. iQOS must be approved by the US Food and Drug Administration before it can be marketed here.

Calantzopoulos told CNBC that one billion people continue to smoke, including 40 million in the US, and his company believes it must give them better alternatives than cigarettes.
 
See video interview here.

Tobacco giant Altria takes 35 percent stake in JUUL, valuing e-cigarette company at $38 billion
 
Last month, Philip Morris International’s stateside partner, Altria, invested $12.8 billion for a 35 percent share of JUUL, the e-cigarette device treasured by teenagers. JUUL has captured some 75 percent of the e-cigarette market in just three years, most of it in the past year.
 
Public Health officials, including FDA Commissioner Scott Gottlieb and Surgeon General Jerome Adams, say e-cigarette use is epidemic among adolescents, and they blame JUUL’s marketing practices for it.
 
As part of the agreement, Altria will give JUUL shelf space, so JUUL pods will be sold right next to Marlboro cigarettes. Altria will also help JUUL distribute its pods through Altria’s 230,000 retail outlets in the US.
 
Ironically, JUUL started out as an anti-tobacco concern, promoting its pods to encourage cigarette smokers to switch to vaping. But its marketing practices mirrored those of the tobacco industry, producing flavored pods that appeal to kids. By relying for its growth on teenagers who have never smoked but are now addicted to nicotine, JUUL may have created a new generation of smokers.
 
The tobacco industry’s quest for nicotine delivery systems that don’t involve smoking is in some ways analogous to the marijuana industry’s product development. While that industry would never admit that smoking pot is harmful, it pursues alternative ways to get high, including a bewildering array of edibles. Can nicotine edibles be far behind?
 
Actually, yes. Two days ago, Forbes announced that Altria has agreed to finance research of one of its subsidiaries, Lexaria Nicotine LLC, in exchange for exclusive license rights to sell “regulatory compliant, oral forms of nicotine” products in the US.
 
Read CNBC story here.

 
Altria to invest $1.8 billion in cannabis company Cronos Group, exits some e-big brands
 
Will marijuana smoking among high school and middle school students give way to marijuana vaping like cigarette smoking has?
 
Altria appears to be hedging its bets. Last month, the company announced it is investing $1.8 billion in the Canadian marijuana company Cronos Group for a 45 percent share. Cigarette sales have slowed, and its customers have turned to other products like e-cigarettes and marijuana.
 
Cronos Group says the deal will help it expand its infrastructure and distribution in Canada and the US if the federal government fully legalizes the drug. It will also enable Cronos to learn how to deal with regulatory issues. Cronos appreciates Altria’s expertise with e-cigarettes and sees an opportunity to customize marijuana vaping products for e-cigarettes.
 
The deal will allow Altria to obtain up to 55 percent of the company at the guaranteed rate of $19 a share.
 
Pictured below is a line of products Cronos makes for medical use.
 
Read CNBC article here.

The Marijuana Report is a weekly e-newsletter published by National Families in Action in partnership with SAM (Smart Approaches to Marijuana).

Visit National Families in Action's website, The Marijuana Report.Org, to learn more about the marijuana story unfolding across the nation.

Subscribe to The Marijuana Report e-newsletter.


The Marijuana Report Staff
Executive Editor
Sue Rusche
Editor
Nicole Carter
IT Consultant
Lee Clontz
Social Media Coordinator
Margarita Eberline
 
We are grateful to our Board of Directors and Senior Adviser for their support of National Families in Action, which produces The Marijuana Report website and e-newsletter.
 
National Families in Action
Board of Directors

William F. Carter, Chairman of the Board
Realtor Berkshire Hathaway HomeServices – Georgia Properties, Atlanta.

Sue Rusche, President and CEO, Atlanta.

Richard L. Brown, Secretary
Attorney (Ret.), Lakewood Ranch, Florida
Founder & Chairman, Sudden Cardiac Arrest Association 

Jeannine F. Adams, Director
President and CEO, J. Addams & Partners, Atlanta.

Jack L. Arbiser, MD, PhD, Director
Thomas J. Lawley Professor of Dermatology
Winship Cancer Institute, Emory University, Atlanta

William H. Avery, Director
Partner (Ret.), Alston & Bird, LLP, Atlanta.

Margarita Eberline, Director
Strategy Director, 360 Marketing Plus, Atlanta.

Robert Margolis, PhD, Director
Founder, Caron Solutions Intensive Outpatient Program, Roswell, Georgia.

Shannon Murphy, MD FAAP, Director
Birmingham, Alabama 
 
Senior Adviser
Kent “Oz” Nelson, Chairman and CEO (Ret.)
United Parcel Service, Atlanta.
 
National Families
National Families
National Families
The MJ Report
The MJ Report
The MJ Report
SAM
SAM
SAM

Note: If someone forwarded this to you, please do not unsubscribe. Clicking the Unsubscribe button will end that person's subscription. Instead, please ask the person who forwarded this to you to take you off his or her forwarding list. Thank you!
Copyright © 2019 National Families in Action, All rights reserved.


unsubscribe from this list    update subscription preferences